<ENAMEX TYPE="PERSON">Stephen J. Redding</ENAMEX>, president of <ENAMEX TYPE="ORGANIZATION">Stephen Redding & Associates Inc.</ENAMEX>, <ENAMEX TYPE="ORGANIZATION">Santa Barbara</ENAMEX>, <ENAMEX TYPE="LOCATION">Calif.</ENAMEX>, said he raised his stake in <ENAMEX TYPE="ORGANIZATION">St. Ives Laboratories Corp.</ENAMEX> to 6.2% of the common shares outstanding.
In a <ENAMEX TYPE="ORGANIZATION">Securities and Exchange Commission</ENAMEX> filing, Mr. <ENAMEX TYPE="PERSON">Redding</ENAMEX> said he holds 434,500 <ENAMEX TYPE="ORGANIZATION">St. Ives</ENAMEX> common shares, including 95,000 shares bought from Sept. 6 to last Friday for $9.75 to $10.99 each.
<ENAMEX TYPE="PERSON">Redding</ENAMEX> said he acquired the <ENAMEX TYPE="LOCATION">St. Ives</ENAMEX> stock as an investment and may purchase more shares.
Mac <ENAMEX TYPE="PERSON">Allen Culver III</ENAMEX>, president and chief operating officer of <ENAMEX TYPE="LOCATION">St. Ives</ENAMEX>, <ENAMEX TYPE="LOCATION">Chatsworth</ENAMEX>, <ENAMEX TYPE="LOCATION">Calif.</ENAMEX>, said ``it's great that he {<ENAMEX TYPE="PERSON">Stephen J. Redding}</ENAMEX> owns a stake. I don't view this as threatening.'' Mr. <ENAMEX TYPE="PERSON">Culver</ENAMEX> said Mr. <ENAMEX TYPE="PERSON">Redding</ENAMEX>'s company is one of <ENAMEX TYPE="LOCATION">St. Ives</ENAMEX>' major customers. <ENAMEX TYPE="LOCATION">St. Ives</ENAMEX> makes and markets personal care products.
